SAM
Shell Asset Management Portfolio holdings
AUM
$2.9B
1-Year Return
24.11%
This Quarter Return
-2.36%
1 Year Return
+24.11%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$2.11B
AUM Growth
-$183M
(-8%)
Cap. Flow
-$75.9M
Cap. Flow
% of AUM
-3.6%
Top 10 Holdings %
Top 10 Hldgs %
29.93%
Holding
1,288
New
24
Increased
138
Reduced
975
Closed
28
Top Buys
| 1 |
Thermo Fisher Scientific
TMO
|
+$3.55M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$3.31M |
| 3 |
Ingredion
INGR
|
+$2.8M |
| 4 |
Regency Centers
REG
|
+$1.95M |
| 5 |
Danaher
DHR
|
+$1.83M |
Top Sells
| 1 |
UnitedHealth
UNH
|
+$6.43M |
| 2 |
Apple
AAPL
|
+$5.06M |
| 3 |
Carlisle Companies
CSL
|
+$4.55M |
| 4 |
NVIDIA
NVDA
|
+$4.23M |
| 5 |
Microsoft
MSFT
|
+$4.05M |
Sector Composition
| 1 | Technology | 30.02% |
| 2 | Financials | 15.27% |
| 3 | Consumer Discretionary | 11.22% |
| 4 | Healthcare | 10.86% |
| 5 | Industrials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
Plexus
PLXS
$3.71B
| $439K | 0.02% |
3,424
-139
| -4% | -$17.8K |
|
502
KeyCorp
KEY
$21.1B
| $438K | 0.02% |
27,374
| – | – |
|
503
Corcept Therapeutics
CORT
$7.55B
| $437K | 0.02% |
3,830
-4,680
| -55% | -$534K |
|
504
Goldman Sachs
GS
$233B
| $433K | 0.02% |
792
-33
| -4% | -$18K |
|
505
Vipshop
VIPS
$8.85B
| $432K | 0.02% |
27,538
-1,702
| -6% | -$26.7K |
|
506
The Ensign Group
ENSG
$9.59B
| $431K | 0.02% |
3,331
+689
| +26% | +$89.2K |
|
507
LPL Financial
LPLA
$27.4B
| $429K | 0.02% |
1,310
-155
| -11% | -$50.8K |
|
508
Fortive
FTV
$16.2B
| $426K | 0.02% |
5,824
-113
| -2% | -$8.27K |
|
509
Essent Group
ESNT
$6.24B
| $422K | 0.02% |
7,305
-299
| -4% | -$17.3K |
|
510
Dynatrace
DT
$14.4B
| $421K | 0.02% |
8,937
| – | – |
|
511
Bank OZK
OZK
$5.89B
| $419K | 0.02% |
9,651
-592
| -6% | -$25.7K |
|
512
DNOW Inc
DNOW
$1.61B
| $418K | 0.02% |
24,473
-483
| -2% | -$8.25K |
|
513
KE Holdings
BEKE
$23.5B
| $416K | 0.02% |
20,682
+488
| +2% | +$9.82K |
|
514
Barrett Business Services
BBSI
$1.18B
| $415K | 0.02% |
10,078
-2,680
| -21% | -$110K |
|
515
Albemarle
ALB
$8.63B
| $414K | 0.02% |
5,750
-150
| -3% | -$10.8K |
|
516
ADMA Biologics
ADMA
$3.76B
| $413K | 0.02% |
20,807
-867
| -4% | -$17.2K |
|
517
First Solar
FSLR
$21.9B
| $413K | 0.02% |
3,265
-68
| -2% | -$8.6K |
|
518
W.R. Berkley
WRB
$27.4B
| $411K | 0.02% |
5,781
-238
| -4% | -$16.9K |
|
519
Comerica
CMA
$8.9B
| $403K | 0.02% |
6,829
-339
| -5% | -$20K |
|
520
Fabrinet
FN
$13.3B
| $403K | 0.02% |
2,040
-104
| -5% | -$20.5K |
|
521
Meritage Homes
MTH
$5.59B
| $403K | 0.02% |
5,685
-1,277
| -18% | -$90.5K |
|
522
Revvity
RVTY
$9.58B
| $402K | 0.02% |
3,799
-438
| -10% | -$46.3K |
|
523
Zscaler
ZS
$43.4B
| $402K | 0.02% |
2,025
+38
| +2% | +$7.54K |
|
524
Futu Holdings
FUTU
$25.3B
| $401K | 0.02% |
3,915
+164
| +4% | +$16.8K |
|
525
KBR
KBR
$6.42B
| $400K | 0.02% |
8,040
-328
| -4% | -$16.3K |
|